| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥875.9B | ¥815.2B | +7.5% |
| Operating Income | ¥149.3B | ¥118.1B | +26.4% |
| Ordinary Income | ¥152.4B | ¥132.0B | +15.5% |
| Net Income | ¥354.5B | ¥96.2B | +272.7% |
| ROE | 20.7% | 7.1% | - |
FY2026 Q3 results demonstrate strong revenue growth with operating income expansion, though net income was significantly influenced by one-time gains. Revenue reached 87.59B yen (YoY +7.5%), operating income 14.93B yen (YoY +26.4%), ordinary income 15.24B yen (YoY +15.5%), and net income 35.45B yen (YoY +268.6%). The substantial net income increase was primarily driven by extraordinary gains of 34.76B yen, predominantly from fixed asset sales of 34.16B yen. Operating performance showed healthy improvement with operating margin expanding to 17.0%, up from the prior year, reflecting solid business fundamentals. The company maintains full-year guidance of 120.0B yen revenue, 20.0B yen operating income, and 38.0B yen net income.
[Profitability] ROE of 20.5% substantially exceeds the company's historical levels, though this includes significant one-time gain contribution. Operating margin of 17.0% represents strong operational efficiency, improving from prior periods. Net profit margin of 40.5% is exceptionally high due to extraordinary gains, with normalized margin estimated significantly lower. ROA of 13.0% reflects efficient asset utilization. [Cash Quality] Cash and deposits of 54.4B yen increased 90.6% YoY, primarily from asset sale proceeds. Short-term debt coverage stands at 9.66x, indicating robust liquidity. [Investment Efficiency] Asset turnover of 0.321 times reflects the capital-intensive nature of operations. Working capital turnover shows deterioration with Days Inventory Outstanding at 397 days and Days Sales Outstanding at 162 days, resulting in Cash Conversion Cycle of 487 days. [Financial Health] Equity ratio estimated at 62.9%, current ratio of 321.0%, and quick ratio of 289.6% demonstrate solid financial stability. Interest-bearing debt of 31.3B yen represents moderate leverage with debt-to-equity ratio of 0.18.
Cash and deposits increased substantially by 25.86B yen (90.6% YoY) to 54.40B yen, primarily reflecting proceeds from fixed asset sales as evidenced by the extraordinary gain of 34.16B yen recorded. Short-term borrowings decreased 4.29B yen (43.2%), indicating debt repayment and improved short-term financial flexibility. Working capital dynamics show mixed signals, with accounts payable increasing 3.09B yen (42.6%), suggesting extended payment terms or increased procurement activity. However, the significant expansion in receivables and inventory days (DSO 162 days, DIO 397 days) indicates approximately 44.0B yen of cash tied up in working capital relative to normal industry levels. Retained earnings increased 31.33B yen (39.8%), reflecting the substantial net income contribution though primarily from non-recurring sources. The company's cash position relative to short-term liabilities of 5.63B yen provides coverage of 9.66x, significantly exceeding normal operating requirements.
Ordinary income of 15.24B yen compared to operating income of 14.93B yen indicates modest non-operating net contribution of approximately 0.31B yen, representing 0.4% of revenue. This comprises primarily financial income and equity method investment gains. The significant divergence occurs at the net income level, where extraordinary gains of 34.76B yen (fixed asset sales of 34.16B yen, investment security sales of 5.17B yen) more than doubled reported net income to 35.45B yen versus operating income of 14.93B yen. Extraordinary gains represent 39.7% of revenue and constitute approximately 97.1% of net income, indicating the core business generated roughly 1.0-2.0B yen of normalized net income. This substantial reliance on one-time items raises material concerns regarding earnings sustainability. The deterioration in working capital metrics (CCC of 487 days versus industry median of 108 days) suggests operating cash flow generation may significantly lag reported earnings, with approximately 44.0B yen of excess working capital deployment compared to industry norms potentially constraining cash realization.
Working capital deterioration represents the most critical near-term risk, with inventory days of 397 days (versus industry median of 109 days) indicating potential obsolescence exposure or demand-supply mismatches affecting approximately 28.9B yen of inventory. Receivables collection extending to 162 days (versus industry median of 83 days) creates 13.5B yen of excess credit exposure and potential bad debt risk. Earnings sustainability concerns arise from 97.1% dependence on extraordinary gains for net income, with normalized operating profitability suggesting annual run-rate net income of 4.0-6.0B yen absent asset sales, creating significant year-over-year comparison challenges for FY2027 unless operational improvements accelerate or additional asset monetization occurs.
[Industry Position] (Reference - Proprietary Analysis) Profitability metrics show mixed positioning within the manufacturing sector. Operating margin of 17.0% significantly exceeds the industry median of 8.3%, ranking in the top quartile and indicating superior operational efficiency. However, normalized net profit margin excluding extraordinary items of approximately 1.5-2.0% would fall below the industry median of 6.3%, suggesting underlying profitability challenges. ROE of 20.5% appears elevated versus industry median of 5.0%, though this primarily reflects one-time gains rather than sustainable returns. Financial health indicators demonstrate strength, with equity ratio of 62.9% aligned with industry median of 63.8% and current ratio of 321.0% substantially exceeding median of 2.84x. Efficiency metrics reveal significant underperformance, with asset turnover of 0.321 substantially below industry median of 0.58, inventory turnover days of 397 versus median of 109, and receivables days of 162 versus median of 83. Revenue growth of 7.5% exceeds industry median of 2.7%, positioning in the third quartile. The company's working capital intensity (CCC of 487 days versus median of 108 days) represents material operational inefficiency requiring management attention. (Industry: Manufacturing, N=98 companies, Period: 2025-Q3, Source: Proprietary analysis)
Operating business momentum demonstrates solid fundamentals with revenue growth of 7.5% exceeding industry median and operating margin expansion to 17.0% ranking in the top quartile, suggesting competitive positioning in core markets. However, working capital management represents a critical area requiring operational improvement, with 44.0B yen of excess cash deployment in receivables and inventory relative to industry norms creating significant opportunity for cash release and return on capital improvement. Earnings normalization considerations are essential for valuation, as FY2026 net income of approximately 35.0B yen includes 34.76B yen of extraordinary gains, implying normalized run-rate earnings of 1.0-2.0B yen absent continued asset sales. The full-year guidance of 38.0B yen net income suggests additional non-recurring gains expected in Q4, making year-over-year comparisons for FY2027 challenging unless operational profitability improves substantially or management pursues strategic portfolio actions.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.